(beta-Asp3)-GRF (human) is a modified growth hormone-releasing factor (GRF) with a beta-aspartic acid substitution at position 3 to increase stability and receptor interaction. This alteration helps probe the interaction between GRF and growth hormone receptors in cellular systems. Researchers use this peptide to explore pituitary hormone regulation and signal transduction pathways in growth and metabolic control.
CAT No: G09015
CAS No:142985-02-2
Synonyms/Alias:(beta-Asp3)-GHRH (human), (beta-Asp3)-Growth Hormone-Releasing Factor (human), (beta-Asp3)-Growth Hormone-Releasing Hormone (human), (beta-Asp3)-Somatocrinin (human), (beta-Asp3)-Somatoliberin (human), (beta-Asp3)-Somatorelin
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.